134 related articles for article (PubMed ID: 23558854)
1. Impairment of locomotor activity induced by the novel N-acylhydrazone derivatives LASSBio-785 and LASSBio-786 in mice.
Silva GA; Kummerle AE; Antunes F; Fraga CA; Barreiro EJ; Zapata-Sudo G; Sudo RT
Braz J Med Biol Res; 2013 Mar; 46(3):263-9. PubMed ID: 23558854
[TBL] [Abstract][Full Text] [Related]
2. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
[TBL] [Abstract][Full Text] [Related]
3. CYP1A2-mediated biotransformation of cardioactive 2-thienylidene-3,4-methylenedioxybenzoylhydrazine (LASSBio-294) by rat liver microsomes and human recombinant CYP enzymes.
Fraga AG; da Silva LL; Fraga CA; Barreiro EJ
Eur J Med Chem; 2011 Jan; 46(1):349-55. PubMed ID: 21144625
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and vasodilatory activity of new N-acylhydrazone derivatives, designed as LASSBio-294 analogues.
Silva AG; Zapata-Sudo G; Kummerle AE; Fraga CA; Barreiro EJ; Sudo RT
Bioorg Med Chem; 2005 May; 13(10):3431-7. PubMed ID: 15848755
[TBL] [Abstract][Full Text] [Related]
5. Effect of S-Se Bioisosteric Exchange on Affinity and Intrinsic Efficacy of Novel
Pedreira JGB; Silva RR; Noël FG; Barreiro EJ
Molecules; 2021 Dec; 26(23):. PubMed ID: 34885946
[TBL] [Abstract][Full Text] [Related]
6. Studies towards the identification of putative bioactive conformation of potent vasodilator arylidene N-acylhydrazone derivatives.
Kümmerle AE; Raimundo JM; Leal CM; da Silva GS; Balliano TL; Pereira MA; de Simone CA; Sudo RT; Zapata-Sudo G; Fraga CA; Barreiro EJ
Eur J Med Chem; 2009 Oct; 44(10):4004-9. PubMed ID: 19500884
[TBL] [Abstract][Full Text] [Related]
7. Sedation and antinociception induced by a new pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivative (LASSBio-873) is modulated by activation of muscarinic receptors.
Mendes TC; Raimundo JM; Nascimento-Junior NM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
Pharmacol Biochem Behav; 2009 Nov; 94(1):70-4. PubMed ID: 19635495
[TBL] [Abstract][Full Text] [Related]
8. N-acylhydrazone improves exercise intolerance in rats submitted to myocardial infarction by the recovery of calcium homeostasis in skeletal muscle.
da Silva JS; Pereira SL; Maia Rdo C; Landgraf SS; Caruso-Neves C; Kümmerle AE; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
Life Sci; 2014 Jan; 94(1):30-6. PubMed ID: 24269214
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Novel Orally Active Tetrahydro-Naphthyl-N-Acylhydrazones with In Vivo Anti-TNF-α Effect and Remarkable Anti-Inflammatory Properties.
Cordeiro NM; Freitas RH; Fraga CA; Fernandes PD
PLoS One; 2016; 11(5):e0156271. PubMed ID: 27227468
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive profile of 2-thienyl-3,4-methylenedioxybenzoylhydrazone is mediated by activation of the A2A adenosine receptor.
Leal CM; Pereira SL; Kümmerle AE; Leal DM; Tesch R; de Sant'Anna CM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
Eur J Med Chem; 2012 Sep; 55():49-57. PubMed ID: 22857782
[TBL] [Abstract][Full Text] [Related]
11. Gastroprotective effects of N-acylarylhydrazone derivatives on ethanol-induced gastric lesions in mice are dependent on the NO/cGMP/K
da Silva Monteiro CE; Franco ÁX; Sousa JAO; Matos VEA; de Souza EP; Fraga CAM; Barreiro EJ; de Souza MHLP; Soares PMG; Barbosa ALR
Biochem Pharmacol; 2019 Nov; 169():113629. PubMed ID: 31491412
[TBL] [Abstract][Full Text] [Related]
12. Anti-atherogenic effects of a new thienylacylhydrazone derivative, LASSBio-788, in rats fed a hypercholesterolemic diet.
da Motta NA; Kümmerle AE; Marostica E; Dos Santos CF; Fraga CA; Barreiro EJ; de Miranda AL; de Brito FC
J Pharmacol Sci; 2013 Sep; 123(1):47-57. PubMed ID: 24018841
[TBL] [Abstract][Full Text] [Related]
13. A novel thienylhydrazone, (2-thienylidene)3,4-methylenedioxybenzoylhydrazine, increases inotropism and decreases fatigue of skeletal muscle.
Gonzalez-Serratos H; Chang R; Pereira EF; Castro NG; Aracava Y; Melo PA; Lima PC; Fraga CA; Barreiro EJ; Albuquerque EX
J Pharmacol Exp Ther; 2001 Nov; 299(2):558-66. PubMed ID: 11602667
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, pharmacological evaluation and electrochemical studies of novel 6-nitro-3,4-methylenedioxyphenyl-N-acylhydrazone derivatives: Discovery of LASSBio-881, a new ligand of cannabinoid receptors.
Duarte CD; Tributino JL; Lacerda DI; Martins MV; Alexandre-Moreira MS; Dutra F; Bechara EJ; De-Paula FS; Goulart MO; Ferreira J; Calixto JB; Nunes MP; Bertho AL; Miranda AL; Barreiro EJ; Fraga CA
Bioorg Med Chem; 2007 Mar; 15(6):2421-33. PubMed ID: 17275312
[TBL] [Abstract][Full Text] [Related]
15. Potent immunosuppressive activity of a phosphodiesterase-4 inhibitor N-acylhydrazone in models of lipopolysaccharide-induced shock and delayed-type hypersensitivity reaction.
Guimarães ET; Dos Santos TB; Silva DKC; Meira CS; Moreira DRM; da Silva TF; Salmon D; Barreiro EJ; Soares MBP
Int Immunopharmacol; 2018 Dec; 65():108-118. PubMed ID: 30312879
[TBL] [Abstract][Full Text] [Related]
16. Vasodilator and antihypertensive effects of a novel N-acylhydrazone derivative mediated by the inhibition of L-type Ca²⁺ channels.
Pereira SL; Kummerle AE; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
Fundam Clin Pharmacol; 2014 Feb; 28(1):29-41. PubMed ID: 22958093
[TBL] [Abstract][Full Text] [Related]
17. Cyclic GMP-dependent vasodilatory properties of LASSBio 294 in rat aorta.
Silva CL; Noël F; Barreiro EJ
Br J Pharmacol; 2002 Jan; 135(1):293-8. PubMed ID: 11786506
[TBL] [Abstract][Full Text] [Related]
18. Novel Regioisomeric Analogues of Naphthyl-
da Costa Salomé D; de Freitas RHCN; Fraga CAM; Fernandes PD
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362349
[TBL] [Abstract][Full Text] [Related]
19. N-acylhydrazone derivative ameliorates monocrotaline-induced pulmonary hypertension through the modulation of adenosine AA2R activity.
Alencar AK; Pereira SL; da Silva FE; Mendes LV; Cunha Vdo M; Lima LM; Montagnoli TL; Caruso-Neves C; Ferraz EB; Tesch R; Nascimento JH; Sant'anna CM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
Int J Cardiol; 2014 May; 173(2):154-62. PubMed ID: 24630383
[TBL] [Abstract][Full Text] [Related]
20. LASSBio-1586, an N-acylhydrazone derivative, attenuates nociceptive behavior and the inflammatory response in mice.
Silva JC; Oliveira Júnior RG; Silva MGE; Lavor ÉM; Soares JMD; Lima-Saraiva SRG; Diniz TC; Mendes RL; Alencar Filho EB; Barreiro EJL; Lima LM; Almeida JRGDS
PLoS One; 2018; 13(7):e0199009. PubMed ID: 30059558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
